130 related articles for article (PubMed ID: 34039950)
1. Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing.
Gebauer N; Künstner A; Ketzer J; Witte HM; Rausch T; Benes V; Zimmermann J; Gebauer J; Merz H; Bernard V; Harder L; Ratjen K; Gesk S; Peter W; Busch Y; Trojok P; von Bubnoff N; Biersack H; Busch H; Feller AC
Blood Cancer J; 2021 May; 11(5):102. PubMed ID: 34039950
[TBL] [Abstract][Full Text] [Related]
2. Comparison of genomic alterations in Epstein-Barr virus-positive and Epstein-Barr virus-negative diffuse large B-cell lymphoma.
Liu F; Tian S; Liu Q; Deng Y; He Q; Shi Q; Chen G; Xu X; Yuan J; Nakamura S; Karube K; Wang Z
Cancer Med; 2024 Feb; 13(4):e6995. PubMed ID: 38457199
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing.
Wang XN; Hong J; Xu YG; Zhang P; Li YY; Dou HL; Li HP
BMC Ophthalmol; 2024 Mar; 24(1):99. PubMed ID: 38438866
[TBL] [Abstract][Full Text] [Related]
4. Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.
Kaulen LD; Denisova E; Hinz F; Hai L; Friedel D; Henegariu O; Hoffmann DC; Ito J; Kourtesakis A; Lehnert P; Doubrovinskaia S; Karschnia P; von Baumgarten L; Kessler T; Baehring JM; Brors B; Sahm F; Wick W
Acta Neuropathol; 2023 Sep; 146(3):499-514. PubMed ID: 37495858
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes.
Zhou Y; Xu Z; Lin W; Duan Y; Lu C; Liu W; Su W; Yan Y; Liu H; Liu L; Zhong M; Zhou J; Zhu H
Front Oncol; 2019; 9():683. PubMed ID: 31403034
[TBL] [Abstract][Full Text] [Related]
6. The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS.
Li JW; Deng C; Zhou XY; Deng R
Heliyon; 2024 Jan; 10(1):e23921. PubMed ID: 38234917
[TBL] [Abstract][Full Text] [Related]
7. Next Generation Sequencing Analysis of Fibrin-associated Large B-cell Lymphoma Reveals Pathogenic Single Nucleotide Variants.
DO J; Yenwongfai LN; DO SI; Na K
Anticancer Res; 2024 Feb; 44(2):665-672. PubMed ID: 38307569
[TBL] [Abstract][Full Text] [Related]
8. The Possible Role of Pathogens and Chronic Immune Stimulation in the Development of Diffuse Large B-Cell Lymphoma.
Gergely L; Udvardy M; Illes A
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540261
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations.
Chang YC; Tsai HJ; Huang TY; Su NW; Su YW; Chang YF; Chen CG; Lin J; Chang MC; Chen SJ; Chen HC; Lim KH; Chang KC; Kuo SH
Ann Hematol; 2024 Apr; ():. PubMed ID: 38671297
[TBL] [Abstract][Full Text] [Related]
10. CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel.
Plaks V; Rossi JM; Chou J; Wang L; Poddar S; Han G; Wang Z; Kuang SQ; Chu F; Davis RE; Vega F; Bashir Z; Jacobson CA; Locke FL; Reagan PM; Rodig SJ; Lekakis LJ; Flinn IW; Miklos DB; Bot A; Neelapu SS
Blood; 2021 Sep; 138(12):1081-1085. PubMed ID: 34041526
[No Abstract] [Full Text] [Related]
11. EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
Chapman JR; Bouska AC; Zhang W; Alderuccio JP; Lossos IS; Rimsza LM; Maguire A; Yi S; Chan WC; Vega F; Song JY
Br J Haematol; 2021 Sep; 194(5):870-878. PubMed ID: 34272731
[TBL] [Abstract][Full Text] [Related]
12. Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.
Carras S; Chartoire D; Mareschal S; Heiblig M; Marçais A; Robinot R; Urb M; Pommier RM; Julia E; Chebel A; Verney A; Bertheau C; Bardel E; Fezelot C; Courtois L; Lours C; Bouska A; Sharma S; Lefebvre C; Rouault JP; Sibon D; Ferrari A; Iqbal J; de Leval L; Gaulard P; Traverse-Glehen A; Sujobert P; Blery M; Salles G; Walzer T; Bachy E; Genestier L
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34043588
[TBL] [Abstract][Full Text] [Related]
13. Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and Interpretation.
Bachy E; Rufibach K; Parreira J; Launonen A; Nielsen T; Hackshaw A
Adv Ther; 2021 Jul; 38(7):3489-3505. PubMed ID: 34041708
[TBL] [Abstract][Full Text] [Related]
14. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.
Fangazio M; Ladewig E; Gomez K; Garcia-Ibanez L; Kumar R; Teruya-Feldstein J; Rossi D; Filip I; Pan-Hammarström Q; Inghirami G; Boldorini R; Ott G; Staiger AM; Chapuy B; Gaidano G; Bhagat G; Basso K; Rabadan R; Pasqualucci L; Dalla-Favera R
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050029
[TBL] [Abstract][Full Text] [Related]
15. Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma.
Chabay P
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072731
[TBL] [Abstract][Full Text] [Related]
16. Direct detection of drug-resistant
Murphy SG; Smith C; Lapierre P; Shea J; Patel K; Halse TA; Dickinson M; Escuyer V; Rowlinson MC; Musser KA
Front Public Health; 2023; 11():1206056. PubMed ID: 37457262
[No Abstract] [Full Text] [Related]
17. Multiplex PCR-based next generation sequencing as a novel, targeted and accurate molecular approach for periprosthetic joint infection diagnosis.
Huang C; Huang Y; Wang Z; Lin Y; Li Y; Chen Y; Chen X; Zhang C; Li W; Zhang W; Fang X; Huang Z
Front Microbiol; 2023; 14():1181348. PubMed ID: 37275128
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Significance of Targeted Next-Generation Sequencing in Central Nervous System Infections in Neurosurgery of Pediatrics.
Li J; Zhang L; Yang X; Wang P; Feng L; Guo E; Chen Y
Infect Drug Resist; 2023; 16():2227-2236. PubMed ID: 37090034
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats.
Li JSZ; Abbasi A; Kim DH; Lippman SM; Alexandrov LB; Cleveland DW
Nature; 2023 Apr; 616(7957):504-509. PubMed ID: 37046091
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of target-based next-generation sequencing for drug-resistant TB.
Mansoor H; Hirani N; Chavan V; Das M; Sharma J; Bharati M; Oswal V; Iyer A; Morales M; Joshi A; Ferlazzo G; Isaakidis P; Ndlovu Z; England K
Int J Tuberc Lung Dis; 2023 Jan; 27(1):41-48. PubMed ID: 36853141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
